Skip to content

ENGN

enGene Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$1.91
+0.00%
Ask drillr

Margins

Gross margin
EBITDA margin
EBIT margin
Net margin
FCF margin
-2.1%
Return on equity
-1.7%
Return on assets
-1.8%
Return on invested capital
0.00x
Asset turnover
-$103.3M
Cash from operations
$3.97
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jul 1, 2026